Abstract
Microglia, the resident immune cells of the brain, regulate neuroinflammation which can lead to secondary neuronal damage and cognitive impairment under pathological conditions. Two of the many molecules that can elicit an inflammatory response from microglia are lipopolysaccharide (LPS), a component of gram-negative bacteria, and interferon gamma (IFNγ), an endogenous pro-inflammatory cytokine. We thoroughly examined the concentration-dependent relationship between LPS from multiple bacterial species and IFNγ in cultured microglia and macrophages. We measured the effects that these immunostimulatory molecules have on pro-inflammatory activity of microglia and used a battery of signaling inhibitors to identify the pathways that contribute to the microglial response. We found that LPS and IFNγ interacted synergistically to induce a pro-inflammatory phenotype in microglia, and that inhibition of JAK1/2 completely blunted the response. We determined that this synergistic action of LPS and IFNγ was likely dependent on JNK and Akt signaling rather than typical pro-inflammatory mediators such as NF-κB. Finally, we demonstrated that LPS derived from Escherichia coli, Klebsiella pneumoniae, and Akkermansia muciniphila can elicit different inflammatory responses from microglia and macrophages, but these responses could be consistently prevented using ruxolitinib, a JAK1/2 inhibitor. Collectively, this work reveals a mechanism by which microglia may become hyperactivated in response to the combination of LPS and IFNγ. Given that elevations in circulating LPS and IFNγ occur in a wide variety of pathological conditions, it is critical to understand the pharmacological interactions between these molecules to develop safe and effective treatments to suppress this process.
Graphical Abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of Data and Material
All data generated during this study are included in this published article and are available from the corresponding author upon reasonable request.
Code Availability
Not applicable.
References
Albeituni S, Verbist KC, Tedrick PE et al (2019) Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis. Blood 134:147–159. https://doi.org/10.1182/blood.2019000761
Apsel B, Blair JA, Gonzalez B et al (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol 4:691–699. https://doi.org/10.1038/nchembio.117
Bagher AM, Young AP, Laprairie RB et al (2020) Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments. J Neurosci Res 98:2496–2509. https://doi.org/10.1002/jnr.24716
Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480–6491. https://doi.org/10.1523/JNEUROSCI.21-17-06480.2001
Bandrés E, Merino J, Vázquez B et al (2000) The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol 96:230–235. https://doi.org/10.1006/clim.2000.4894
Banks WA, Gray AM, Erickson MA et al (2015) Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 12:223. https://doi.org/10.1186/s12974-015-0434-1
Bennett BL, Sasaki DT, Murray BW et al (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681–13686. https://doi.org/10.1073/pnas.251194298
Blacher E, Bashiardes S, Shapiro H et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572:474–480. https://doi.org/10.1038/s41586-019-1443-5
Bradley D, Smith AJ, Blaszczak A et al (2022) Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity. Nat Commun 13:5606. https://doi.org/10.1038/s41467-022-33067-5
Brenchley JM, Price DA, Schacker TW et al (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365–1371. https://doi.org/10.1038/nm1511
Brown GC (2019) The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 16:180. https://doi.org/10.1186/s12974-019-1564-7
Bruewer M, Utech M, Ivanov AI et al (2005) Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19:923–933. https://doi.org/10.1096/fj.04-3260com
Calfee DP (2017) Recent advances in the understanding and management of Klebsiella pneumoniae. F1000Res 6:1760. https://doi.org/10.12688/f1000research.11532.1
Chai Q, He WQ, Zhou M et al (2014) Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol 88:4698–4710. https://doi.org/10.1128/JVI.03149-13
Cherry JD, Olschowka JA, O’Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https://doi.org/10.1186/1742-2094-11-98
Chevalier C, Stojanović O, Colin DJ et al (2015) Gut microbiota orchestrates energy homeostasis during cold. Cell 163:1360–1374. https://doi.org/10.1016/j.cell.2015.11.004
Chhor V, Le Charpentier T, Lebon S et al (2013) Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun 32:70–85. https://doi.org/10.1016/j.bbi.2013.02.005
Choi I, Wang M, Yoo S et al (2023) Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence. Nat Cell Biol 25:963–974. https://doi.org/10.1038/s41556-023-01158-0
Chou T-C (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681. https://doi.org/10.1124/pr.58.3.10
Chou T-C (2018) The combination index (CI < 1) as the definition of synergism and of synergy claims. Synergy 7:49–50. https://doi.org/10.1016/j.synres.2018.04.001
Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55. https://doi.org/10.1016/0065-2571(84)90007-4
Colasanti M, Persichini T, Di Pucchio T et al (1995) Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor α stimulation. Neurosci Lett 200:144–146. https://doi.org/10.1016/0304-3940(95)12101-9
Cuenda A, Rouse J, Doza YN et al (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229–233. https://doi.org/10.1016/0014-5793(95)00357-f
Daniels BP, Klein RS (2015) Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog 11:e1005096. https://doi.org/10.1371/journal.ppat.1005096
Davalos D, Grutzendler J, Yang G et al (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758. https://doi.org/10.1038/nn1472
De S, Wirthensohn DC, Flagmeier P et al (2019) Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms. Nat Commun 10:1541. https://doi.org/10.1038/s41467-019-09477-3
Desai RJ, Varma VR, Gerhard T et al (2022) Comparative risk of Alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents. JAMA Netw Open 5:e226567. https://doi.org/10.1001/jamanetworkopen.2022.6567
Ding M, St Pierre BA, Parkinson JF et al (1997) Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia: a kinetic analysis. J Biol Chem 272:11327–11335. https://doi.org/10.1074/jbc.272.17.11327
Evans ME, Pollack M (1993) Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis 167:1336–1343. https://doi.org/10.1093/infdis/167.6.1336
Everard A, Belzer C, Geurts L et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110:9066–9071. https://doi.org/10.1073/pnas.1219451110
Favata MF, Horiuchi KY, Manos EJ et al (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623–18632. https://doi.org/10.1074/jbc.273.29.18623
Federici S, Kredo-Russo S, Valdés-Mas R et al (2022) Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185:2879-2898.e24. https://doi.org/10.1016/j.cell.2022.07.003
Fellner L, Irschick R, Schanda K et al (2013) Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia. Glia 61:349–360. https://doi.org/10.1002/glia.22437
Forsyth CB, Shannon KM, Kordower JH et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS ONE 6:e28032. https://doi.org/10.1371/journal.pone.0028032
Gaber T, Strehl C, Buttgereit F (2017) Metabolic regulation of inflammation. Nat Rev Rheumatol 13:267–279. https://doi.org/10.1038/nrrheum.2017.37
Garvey EP, Oplinger JA, Furfine ES et al (1997) 1400W Is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959–4963. https://doi.org/10.1074/jbc.272.8.4959
Gavegnano C, Haile WB, Hurwitz S et al (2019) Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro. J Neuroinflammation 16:182. https://doi.org/10.1186/s12974-019-1565-6
Ginhoux F, Greter M, Leboeuf M et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841–845. https://doi.org/10.1126/science.1194637
Guttenplan KA, Stafford BK, El-Danaf RN et al (2020) Neurotoxic reactive astrocytes drive neuronal death after retinal injury. Cell Rep 31:107776. https://doi.org/10.1016/j.celrep.2020.107776
Guttenplan KA, Weigel MK, Prakash P et al (2021) Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature 599:102–107. https://doi.org/10.1038/s41586-021-03960-y
Guzman-Martinez L, Maccioni RB, Andrade V et al (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. https://doi.org/10.3389/fphar.2019.01008
Hashioka S, Klegeris A, Schwab C et al (2010) Differential expression of interferon-γ receptor on human glial cells in vivo and in vitro. J Neuroimmunol 225:91–99. https://doi.org/10.1016/j.jneuroim.2010.04.023
Hayes MP, Freeman SL, Donnelly RP (1995) IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine 7:427–435. https://doi.org/10.1006/cyto.1995.0058
Held TK, Weihua X, Yuan L et al (1999) Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 67:206–212. https://doi.org/10.1128/IAI.67.1.206-212.1999
Hoogland ICM, Houbolt C, van Westerloo DJ et al (2015) Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation 12:114. https://doi.org/10.1186/s12974-015-0332-6
Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565–581. https://doi.org/10.1038/s41582-019-0244-7
Hughes C, Choi ML, Yi J-H et al (2020) Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death. Commun Biol 3:79. https://doi.org/10.1038/s42003-020-0792-9
Hussain S, Johnson CG, Sciurba J et al (2020) TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury. eLife 9:e50458. https://doi.org/10.7554/eLife.50458
Jang Y, Lee W-J, Lee HS et al (2021) Tofacitinib treatment for refractory autoimmune encephalitis. Epilepsia 62:e53–e59. https://doi.org/10.1111/epi.16848
Jones RS, Minogue AM, Fitzpatrick O, Lynch MA (2015) Inhibition of JAK2 attenuates the increase in inflammatory markers in microglia from APP/PS1 mice. Neurobiol Aging 36:2716–2724. https://doi.org/10.1016/j.neurobiolaging.2015.04.018
Kamal H, Tan GC, Ibrahim SF et al (2020) Alcohol use disorder, neurodegeneration, Alzheimer’s and Parkinson’s disease: interplay between oxidative stress, neuroimmune response and excitotoxicity. Front Cell Neurosci 14:282. https://doi.org/10.3389/fncel.2020.00282
Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ (1983) Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol 130:1784–1789
Katze MG, He Y, Gale M (2002) Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2:675–687. https://doi.org/10.1038/nri888
Kell D, Pretorius E (2015) On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol 7:1339–1377. https://doi.org/10.1039/C5IB00158G
Kimura A, Naka T, Muta T et al (2005) Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK–STAT. Proc Natl Acad Sci 102:17089–17094. https://doi.org/10.1073/pnas.0508517102
Krasnow SM, Knoll JG, Verghese SC et al (2017) Amplification and propagation of interleukin-1β signaling by murine brain endothelial and glial cells. J Neuroinflammation 14:133. https://doi.org/10.1186/s12974-017-0908-4
Kwon HS, Koh S-H (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9:42. https://doi.org/10.1186/s40035-020-00221-2
Lajqi T, Lang G-P, Haas F et al (2019) Memory-like inflammatory responses of microglia to rising doses of LPS: key role of PI3Kγ. Front Immunol 10:475729
Lajqi T, Stojiljkovic M, Williams DL et al (2020) Memory-like responses of brain microglia are controlled by developmental state and pathogen dose. Front Immunol 11:546415. https://doi.org/10.3389/fimmu.2020.546415
Landry RP, Jacobs VL, Romero-Sandoval EA, DeLeo JA (2012) Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: In vitro evidence for differential responses in human and rodent microglia and macrophages. Exp Neurol 234:340–350. https://doi.org/10.1016/j.expneurol.2011.11.006
Langer V, Vivi E, Regensburger D et al (2019) IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin–directed vascular barrier disruption. J Clin Invest 129:4691–4707. https://doi.org/10.1172/JCI124884
Lashgari N-A, Roudsari NM, Momtaz S et al (2021) The involvement of JAK/STAT signaling pathway in the treatment of Parkinson’s disease. J Neuroimmunol 361:577758. https://doi.org/10.1016/j.jneuroim.2021.577758
Lehnardt S (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58:253–263. https://doi.org/10.1002/glia.20928
Lei H, Crawford MS, McCole DF (2021) JAK-STAT pathway regulation of intestinal permeability: pathogenic roles and therapeutic opportunities in inflammatory bowel disease. Pharmaceuticals (basel) 14:840. https://doi.org/10.3390/ph14090840
Li J, Lin S, Vanhoutte PM et al (2016) Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe−/− mice. Circulation 133:2434–2446. https://doi.org/10.1161/CIRCULATIONAHA.115.019645
Liddelow SA, Guttenplan KA, Clarke LE et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487. https://doi.org/10.1038/nature21029
Lowe PP, Morel C, Ambade A et al (2020) Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations. J Neuroinflammation 17:296. https://doi.org/10.1186/s12974-020-01972-5
Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42:145–151. https://doi.org/10.1016/j.cyto.2008.01.006
Mathys H, Adaikkan C, Gao F et al (2017) Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep 21:366–380. https://doi.org/10.1016/j.celrep.2017.09.039
Matsunaga N, Tsuchimori N, Matsumoto T, Ii M (2011) TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 79:34–41. https://doi.org/10.1124/mol.110.068064
Mazon JN, de Mello AH, Ferreira GK, Rezin GT (2017) The impact of obesity on neurodegenerative diseases. Life Sci 182:22–28. https://doi.org/10.1016/j.lfs.2017.06.002
McGarry T, Orr C, Wade S et al (2018) JAK/STAT Blockade Alters Synovial Bioenergetics, Mitochondrial Function, and Proinflammatory Mediators in Rheumatoid Arthritis. Arthritis Rheumatol 70:1959–1970. https://doi.org/10.1002/art.40569
Melief J, Koning N, Schuurman KG et al (2012) Phenotyping primary human microglia: Tight regulation of LPS responsiveness. Glia 60:1506–1517. https://doi.org/10.1002/glia.22370
Minogue AM, Barrett JP, Lynch MA (2012) LPS-induced release of IL-6 from glia modulates production of IL-1β in a JAK2-dependent manner. J Neuroinflammation 9:126. https://doi.org/10.1186/1742-2094-9-126
Mishra M, Kane AE, Young AP, Howlett SE (2023) Age, sex, and frailty modify the expression of common reference genes in skeletal muscle from ageing mice. Mech Ageing Dev 210:111762. https://doi.org/10.1016/j.mad.2022.111762
Mohr AE, Crawford M, Jasbi P et al (2022) Lipopolysaccharide and the gut microbiota: considering structural variation. FEBS Lett 596:849–875. https://doi.org/10.1002/1873-3468.14328
Monteiro S, Roque S, Marques F et al (2017) Brain interference: revisiting the role of IFNγ in the central nervous system. Prog Neurobiol 156:149–163. https://doi.org/10.1016/j.pneurobio.2017.05.003
Monzón-Sandoval J, Burlacu E, Agarwal D et al (2022) Lipopolysaccharide distinctively alters human microglia transcriptomes to resemble microglia from Alzheimer’s disease mouse models. Dis Model Mech 15:dmm049349. https://doi.org/10.1242/dmm.049349
Murray CL, Skelly DT, Cunningham C (2011) Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. J Neuroinflammation 8:50. https://doi.org/10.1186/1742-2094-8-50
Nagamoto-Combs K, Kulas J, Combs CK (2014) A novel cell line from spontaneously immortalized murine microglia. J Neurosci Methods 233:187–198. https://doi.org/10.1016/j.jneumeth.2014.05.021
Navarro G, Borroto-Escuela D, Angelats E et al (2018) Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia. Brain Behav Immun 67:139–151. https://doi.org/10.1016/j.bbi.2017.08.015
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318. https://doi.org/10.1126/science.1110647
O’Brien A, Hanlon MM, Marzaioli V et al (2021) Targeting JAK-STAT signalling alters PsA synovial fibroblast pro-inflammatory and metabolic function. Front Immunol 12:672461. https://doi.org/10.3389/fimmu.2021.672461
Okugawa S, Ota Y, Kitazawa T et al (2003) Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. Am J Physiol Cell Physiol 285:C399–C408. https://doi.org/10.1152/ajpcell.00026.2003
Orihuela R, McPherson CA, Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173:649–665. https://doi.org/10.1111/bph.13139
Pacifico L, Renzo LD, Anania C et al (2006) Increased T-helper interferon-γ-secreting cells in obese children. Eur J Endocrinol 154:691–697. https://doi.org/10.1530/eje.1.02138
Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10:217–224. https://doi.org/10.1038/nrneurol.2014.38
Perry VH, Nicoll JAR, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6:193–201. https://doi.org/10.1038/nrneurol.2010.17
Qin H, Buckley JA, Li X et al (2016) Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36:5144–5159. https://doi.org/10.1523/JNEUROSCI.4658-15.2016
Quan N, Whiteside M, Herkenham M (1998) Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83:281–293. https://doi.org/10.1016/s0306-4522(97)00350-3
Quintás-Cardama A, Vaddi K, Liu P et al (2010) Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood 115:3109–3117. https://doi.org/10.1182/blood-2009-04-214957
Raparelli V, Basili S, Carnevale R et al (2017) Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 65:571–581. https://doi.org/10.1002/hep.28853
Raschke WC, Baird S, Ralph P, Nakoinz I (1978) Functional macrophage cell lines transformed by abelson leukemia virus. Cell 15:261–267. https://doi.org/10.1016/0092-8674(78)90101-0
Rashid T, Ebringer A, Wilson C (2013) The role of Klebsiella in Crohn’s disease with a potential for the use of antimicrobial measures. Int J Rheumatol 2013:610393. https://doi.org/10.1155/2013/610393
Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE (2009) CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 29:11982–11992. https://doi.org/10.1523/JNEUROSCI.3158-09.2009
Rietschel ET, Kirikae T, Schade FU et al (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217–225. https://doi.org/10.1096/fasebj.8.2.8119492
Rodriguez S, Hug C, Todorov P et al (2021) Machine learning identifies candidates for drug repurposing in Alzheimer’s disease. Nat Commun 12:1033. https://doi.org/10.1038/s41467-021-21330-0
Roy ER, Wang B, Wan Y-W et al (2020) Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest 130:1912–1930. https://doi.org/10.1172/JCI133737
Rusek M, Smith J, El-Khatib K et al (2023) The role of the JAK/STAT signaling pathway in the pathogenesis of Alzheimer’s Disease: new potential treatment target. Int J Mol Sci 24:864. https://doi.org/10.3390/ijms24010864
Sandiego CM, Gallezot J-D, Pittman B et al (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci USA 112:12468–12473. https://doi.org/10.1073/pnas.1511003112
Sayoc-Becerra A, Krishnan M, Fan S et al (2020) The JAK-inhibitor tofacitinib rescues human intestinal epithelial cells and colonoids from cytokine-induced barrier dysfunction. Inflamm Bowel Dis 26:407–422. https://doi.org/10.1093/ibd/izz266
Schiltz JC, Sawchenko PE (2002) Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22:5606–5618. https://doi.org/10.1523/JNEUROSCI.22-13-05606.2002
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189. https://doi.org/10.1189/jlb.0603252
Schroder K, Sweet MJ, Hume DA (2006) Signal integration between IFNγ and TLR signalling pathways in macrophages. Immunobiology 211:511–524. https://doi.org/10.1016/j.imbio.2006.05.007
Schwartz DM, Bonelli M, Gadina M, O’Shea JJ (2016) Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol 12:25–36. https://doi.org/10.1038/nrrheum.2015.167
Smith AM, Dragunow M (2014) The human side of microglia. Trends Neurosci 37:125–135. https://doi.org/10.1016/j.tins.2013.12.001
Sun J, Ludvigsson JF, Ingre C et al (2022) Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: a nationwide nested case-control study in Sweden. PLoS Med. https://doi.org/10.1371/journal.pmed.1004092
Takashima K, Matsunaga N, Yoshimatsu M et al (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br J Pharmacol 157:1250–1262. https://doi.org/10.1111/j.1476-5381.2009.00297.x
Taylor JM, Moore Z, Minter MR, Crack PJ (2018) Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease. J Neural Transm (Vienna) 125:797–807. https://doi.org/10.1007/s00702-017-1745-4
Too LK, Ball HJ, McGregor IS, Hunt NH (2014) The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav Immun 40:252–268. https://doi.org/10.1016/j.bbi.2014.02.020
Trettel F, Rigamonti D, Hilditch-Maguire P et al (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799–2809. https://doi.org/10.1093/hmg/9.19.2799
Tsiavou A, Hatziagelaki E, Chaidaroglou A et al (2005) Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 31:135–141. https://doi.org/10.1016/j.cyto.2005.02.011
Utech M, Ivanov AI, Samarin SN et al (2005) Mechanism of IFN-γ-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16:5040–5052. https://doi.org/10.1091/mbc.E05-03-0193
van Langevelde P, Kwappenberg KMC, Groeneveld PHP et al (1998) Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS. Antimicrob Agents Chemother 42:739–743
Vargas-Caraveo A, Sayd A, Maus SR et al (2017) Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions. Sci Rep 7:13113. https://doi.org/10.1038/s41598-017-13302-6
Vatanen T, Kostic AD, d’Hennezel E et al (2016) Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165:842–853. https://doi.org/10.1016/j.cell.2016.04.007
Villarino AV, Kanno Y, O’Shea JJ (2017) Mechanisms and consequences of Jak–STAT signaling in the immune system. Nat Immunol 18:374–384. https://doi.org/10.1038/ni.3691
Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241–5248
Vogel SN, Fitzgerald KA, Fenton MJ (2003) TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3:466–477. https://doi.org/10.1124/mi.3.8.466
Waelchli R, Bollbuck B, Bruns C et al (2006) Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK. Bioorg Med Chem Lett 16:108–112. https://doi.org/10.1016/j.bmcl.2005.09.035
Widmann CN, Heneka MT (2014) Long-term cerebral consequences of sepsis. Lancet Neurol 13:630–636. https://doi.org/10.1016/S1474-4422(14)70017-1
Wright SD, Ramos RA, Tobias PS et al (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433. https://doi.org/10.1126/science.1698311
Yang S, Qin C, Hu Z-W et al (2021) Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system. Neurobiol Dis 152:105290. https://doi.org/10.1016/j.nbd.2021.105290
Ye J, Ortaldo JR, Conlon K et al (1995) Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol 58:225–233. https://doi.org/10.1002/jlb.58.2.225
Young AP, Adderley SJ, Bagher AM, Denovan-Wright EM (2022) Protein-protein allosteric effects on cannabinoid receptor heteromer signaling. In: Laprairie RB (ed) Allosteric modulation of G protein-coupled receptors. Academic Press, pp 71–96
Young AP, Denovan-Wright EM (2022a) Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro. Brain Behav Immun 105:29–43. https://doi.org/10.1016/j.bbi.2022.06.011
Young AP, Denovan-Wright EM (2022b) The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma. J Neuroimmunol 372:577971. https://doi.org/10.1016/j.jneuroim.2022.577971
Young AP, Denovan-Wright EM (2022c) The dynamic role of microglia and the endocannabinoid system in neuroinflammation. Front Pharmacol. https://doi.org/10.3389/fphar.2021.806417
Young AP, Landry CF, Jackson DJ, Wyeth RC (2019) Tissue-specific evaluation of suitable reference genes for RT-qPCR in the pond snail, Lymnaea Stagnalis. Peerj 7:e7888. https://doi.org/10.7717/peerj.7888
Zhang R, Miller RG, Gascon R et al (2009) Circulating endotoxin and systemic immune activation in sporadic Amyotrophic Lateral Sclerosis (sALS). J Neuroimmunol 206:121–124. https://doi.org/10.1016/j.jneuroim.2008.09.017
Zhang F, Wei K, Slowikowski K et al (2019) Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20:928–942. https://doi.org/10.1038/s41590-019-0378-1
Zhang Q, Su X, Zhang C et al (2022) Klebsiella pneumoniae induces inflammatory bowel disease through caspase-11-mediated IL18 in the gut epithelial cells. Cell Mol Gastroenterol Hepatol. https://doi.org/10.1016/j.jcmgh.2022.11.005
Zhou K (2017) Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies. J Funct Foods 33:194–201. https://doi.org/10.1016/j.jff.2017.03.045
Zrein A, Bagher AM, Young AP et al (2020) Endothelin receptor heteromerization inhibits β-arrestin function in HEK293 cells. Can J Physiol Pharmacol 98:531–540. https://doi.org/10.1139/cjpp-2019-0620
Funding
This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to E.M.D-W. (grant # RGPIN-2019-37999) and an NSERC Alexander Graham Bell Canada Graduate Scholarship (CGS-D) to A.P.Y.
Author information
Authors and Affiliations
Contributions
A.P.Y. conceived the study, performed the experiments, analyzed and interpreted the data, and wrote the manuscript. E.M.D-W. conceived the study, interpreted the data, and edited the manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Young, A.P., Denovan-Wright, E.M. JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia. J Neuroimmune Pharmacol 19, 14 (2024). https://doi.org/10.1007/s11481-024-10115-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11481-024-10115-z